Loading...
Loading...
Holder clone rankings through .
Of the 6 tracked institutions holding ORMP, 2 have a 3-year clone track record — 1 of them beat the S&P. Average holder's clone alpha: +1.6pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 6 tracked institutional investors we monitor, ORMP (ORAMED PHARMACEUTICALS INC) is held with a combined value of $12.56M across 2,690,417 shares. The largest holder is BlackRock, Inc. with a position worth $8.59M. 5 funds increased their holdings.
Total Institutional Value
$12.56M
Total Shares Held
2,690,417
Institutional Holders
6
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $8.59M | 0.00% | +14.4% |
| 2 | STATE STREET CORP | $2.18M | 0.00% | +92.8% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $1.37M | 0.00% | +60.1% |
| 4 | CITADEL ADVISORS LLC | $279.47K | 0.00% | +44.0% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | $131.00K | 0.00% | - |
| 6 | FMR LLC | $6.21K | 0.00% | +1826.1% |
| Member | Type | Date |
|---|---|---|
| Brad Knott | Sell | Jan 10, 2025 |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ORMP with a position worth $8.59M, representing 0.00% of their portfolio. In total, 6 institutional investors hold ORMP with a combined value of $12.56M.
Institutional investors hold $12.56M worth of ORMP stock across 6 positions. The largest institutional holder is BlackRock, Inc. with $8.59M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ORMP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
None this quarter.
| — |
| 6.0% |
| 2026-08-14 |
SEC Schedule 13D (activist) and 13G (passive) filings for ORMP. Filed when an investor acquires 5%+ ownership.
Last Close
$3.89
2026-11-18
YTD
+33.7%
52% of 52-week range